T cell immunotherapy for leukaemia in preclinical setting

Idelalisib and rituximab for previously treated chronic lymphocytic leukaemia (CLL)

Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia (AML)

Comment: Transplantation and short telomeres increase the risk of cognitive impairment

Equality of access to transplant for ethnic minority patients

PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant

Exercise improves drug-associated joint pain in breast cancer survivors

Benefit of breast cancer screening more consistent across studies than previously understood

Avoiding radiotherapy is an option for some older patients with breast cancer

Anastrozole cuts breast cancer cases by more than 50% in high risk women

Patients with metastatic breast cancer may not benefit from surgery and radiation after chemotherapy

New agents in CLL